Curi Wealth Management’s Charles River Laboratories CRL Stock Holding History

Curi Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40,018	Closed	-$9.46M	–	24
2023 Q4	$9.46M	Sell	40,018 -8,699	-18%	-$1.71M	1.31%	26
2023 Q3	$9.55M	Sell	48,717 -2,591	-5%	-$532K	1.46%	25
2023 Q2	$10.8M	Sell	51,308 -3,190	-6%	-$635K	1.46%	24
2023 Q1	$11M	Sell	54,498 -1,653	-3%	-$375K	1.58%	22
2022 Q4	$12.2M	Buy	56,151 +19,642	+54%	+$4.29M	1.72%	21
2022 Q3	$7.18M	Sell	36,509 -3,907	-10%	-$843K	1.19%	33
2022 Q2	$8.65M	Buy	40,416 +16,104	+66%	+$3.94M	1.66%	25
2022 Q1	$6.9M	Buy	+24,312	New	+$7.5M	1.2%	36

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Curi Wealth Management's CRL Position: Q1 2024 in Review

Curi Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 40,018 shares — an estimated $9.46M sold.

Curi Wealth Management first reported a position in CRL in Q1 2022 and held it in 8 quarters. The position peaked at $12.2M in Q4 2022. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

Curi Wealth Management reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
Curi Wealth Management sold 40,018 Charles River Laboratories shares in Q1 2024, an estimated $9.46M.
Curi Wealth Management first reported a position in Charles River Laboratories in Q1 2022 and held it in 8 quarters.
Curi Wealth Management's Charles River Laboratories position peaked at $12.2M in Q4 2022.
676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Curi Wealth Management's 13F filing for Q1 2024.